On this page
What each program costs in West Virginia
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 15 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 16 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 17 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 18 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the West Virginia Public Employees Insurance Agency (PEIA) cover GLP-1s for weight loss?
PEIA's actuarial report says the agency has put policies in place to limit GLP-1 drugs prescribed for weight loss alone.
Does West Virginia Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
West Virginia Medicaid's criteria say weight-loss drugs are typically a benefit exclusion, and they limit Wegovy to heart event prevention or a liver condition and Zepbound to sleep apnea. Read from state documents Nov 6, 2026.
What West Virginia Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. West Virginia Department of Human Services, Bureau for Medical Services.
WegovyNo
Only considered for preventing another heart event or for a liver condition (MASH). Prior authorization required, BMI 27 or higher for the heart use.
“Agents used for the purpose of weight loss are typically a benefit exclusion. Coverage of Wegovy will only be considered for the secondary prevention of a cardiovascular event and/or a diagnosis of MASH.”
West Virginia Bureau for Medical Services, Office of Pharmacy Services · Effective Jan 1, 2026 · read Nov 6, 2026
ZepboundNo
Only considered for moderate to severe sleep apnea in adults with obesity. Prior authorization required, BMI 30 or higher.
“Coverage of Zepbound will only be considered for a diagnosis of OSA in adults with obesity.”
West Virginia Bureau for Medical Services, Office of Pharmacy Services · Effective Jul 1, 2025 · read Nov 6, 2026
OzempicNo
Injection is preferred in the diabetes class with a type 2 diabetes diagnosis. Provider manual lists weight-loss agents as non-covered.
“Preferred agents may be authorized with a diagnosis of Diabetes Mellitus Type II.”
West Virginia Bureau for Medical Services, Office of Pharmacy Services · Effective Oct 1, 2026 · read Nov 6, 2026
“Agents used for weight loss, anorexia, or weight gain, including binge-eating disorder”
West Virginia Bureau for Medical Services, Office of Pharmacy Services · Effective Jul 1, 2024 · read Nov 6, 2026
MounjaroNo
Non-preferred in the diabetes class. Requires a type 2 diabetes diagnosis and other criteria. Provider manual lists weight-loss agents as non-covered.
“Non-preferred agents will only be approved (in six-month intervals) if ALL of the following criteria have been met: 1. Diagnosis of Diabetes Mellitus Type II.”
West Virginia Bureau for Medical Services, Office of Pharmacy Services · Effective Oct 1, 2026 · read Nov 6, 2026
“Agents used for weight loss, anorexia, or weight gain, including binge-eating disorder”
West Virginia Bureau for Medical Services, Office of Pharmacy Services · Effective Jul 1, 2024 · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from West Virginia Department of Human Services, Bureau for Medical Services documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
307 prescriptions
Ozempic and Mounjaro, 2025
77,684 prescriptions
Neighbours covering weight loss
1 of 5
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your West Virginia Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed West Virginia Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether West Virginia Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does West Virginia Medicaid pay for?
94,999 GLP-1 prescriptions in 2025, 24th of the 50 states and DC, with $88.1 million reimbursed before rebates. Counting the share other payers covered, $91.6 million.
Prescriptions, 2025
94,999
24th of 51
Medicaid paid
$88.1M
24th of 51, before rebates
Per prescription
$927
$1,051 nationally
Weight-loss brands
0.3%
47th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. West Virginia is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 0.3% of West Virginia Medicaid's GLP-1 prescriptions in 2025 (307). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was West Virginia Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 75,656 | 80% | $71.8 million | $949 |
| Trulicity | 15,569 | 16% | $14.4 million | $928 |
| Mounjaro | 2,028 | 2.1% | $767,282 | $378 |
| Victoza | 781 | 0.8% | $476,559 | $610 |
| Liraglutide (generic) | 557 | 0.6% | $241,072 | $433 |
| Zepboundapproved for weight management | 229 | 0.2% | $229,924 | $1,004 |
| Rybelsus | 101 | 0.1% | $47,903 | $474 |
| Wegovyapproved for weight management | 78 | 0.1% | $52,153 | $669 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
On Medicare in West Virginia?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
West Virginia and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
1 of the 5 states next to West Virginia covers GLP-1s for weight loss through Medicaid: Virginia. None has a lower cash floor than West Virginia's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| West Virginia | Not covered | 18 | $39/mo |
| Kentucky | Not covered | 19 | $39/moWellmedr |
| Maryland | Not covered | 19 | $39/moWellmedr |
| Ohio | Not covered in part | 19 | $39/moWellmedr |
| Pennsylvania | Not covered | 19 | $39/moWellmedr |
| Virginia | Covered | 19 | $39/moWellmedr |





















